Company / Net Debt per Share
PTC Therapeutics, Inc. Net Debt per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$6.53
FY2024
5-year range
-$6.53 / $4.12
FY2020-FY2024
Trend
-54.1%
vs FY2023
Sector context
#79 of 82
Health Care
What the data says
Among 82 Health Care companies, PTC Therapeutics, Inc. is in the top 4% for net debt per share. Net Debt per Share has fluctuated over the past 9 years, ranging from $-6.53 in FY2024 to $4.12 in FY2022.
Based on SEC 10-K filings.
-6.53 in FY2024.
Improved from $4.12 to $-6.53 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 82This company -$6.53 Sector average $1.13
▼
-677.7% below sector average
Key checks
Key Insights
- In FY2024, net debt per share decreased 54.1% year-over-year.
- Ranks #79 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$6.53 | -54.1% |
| FY2023 | -$4.24 | -202.8% |
| FY2022 | $4.12 | +211.7% |
| FY2021 | $1.32 | -18.4% |
| FY2020 | $1.62 | +1535.3% |
| FY2019 | $0.10 | +114.6% |
| FY2018 | -$0.68 | -169.7% |
| FY2017 | $0.97 | -17.4% |
| FY2016 | $1.18 | +14.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026